"Indap" capsules. Litaelo tsa tšebeliso

Lithethefatsi "Indap" - antihypertensive lithethefatsi tseo nka khato ka vasodilator le diuretic. Tloaelehileng ho lokolloa mofuta o mong oa lithethefatsi e - capsules nang 2,5 mg, indapamide hemihydrate. Medicine "Indap" abetsoe ho fokotsa khatello ea mali e phahameng ea ho phekola sa kgatelelo ya madi.

Molao-motheo oa ketso ea lithethefatsi ke tšoanang le diuretics thiazide, eo lingaka tsebisahala lefatšeng ka bophara, e lokela ho ba teng ka leqheka la leha e le efe ea phekolo ea kgatelelo ya madi. Mabapi le "Indap" ho lokisetsa litaelo bakeng sa ho sebelisoa ho bontša hore bohato lona thehiloeng tlōla reabsorption tsa ions sodium ka karolo holim'a ka sekgoqetsane la Henle. Ka tsela eo, potlakisa excretion ea magnesium, potassium, sodium le chloride excretion. Lithethefatsi khetha ho na le masakana le "ea liehang" k'halsiamo metjha e, fokotsa pheriferale vascular hanyetsa eketsa elasticity ea mabota bona.

Kaha e ke ke a hlokomela phello ea lithethefatsi ho ka metabolism tsa lik'habohaedreite le lipids ka lero la mali mali, e ka abeloa ho diabetics. Leha ho le joalo, le exacerbation joalo oa lefu la tsoekere ke ketoacidosis, moriana "Indap" thuto e ho boletsoe, ha ho laela.

Hoa hlokomeleha hore dosages tse phahameng tsa moriana o sesosa eketsehileng moroto khumo, empa ka tekanyo e sa khatello ea mali theola litla e sa faneng. Ke ka lebaka leo moriana "Indap" eletswa ho nka ho pheta-pheta le ho feto-fetohe, e leng tla kenya letsoho hore ho fokotseha le khatello, ho qala ho tloha bekeng ea bobeli ea thupelo.

Lithethefatsi "Indap". Litaelo ho sebelisoa. Contraindications

Ha e le contraindications keneletseng ho sebelisoa ho, lenane la lithethefatsi "Indap" a pharaletseng haholo. Ka ho khetheha, lithethefatsi le mafolo-folo e contraindicated ka anuria, tšenyo e sebete, hypokalemia, lefu renal, 'me le tsona ka taba ea ho se mamellane indapamide. Hape, lithethefatsi e sa kgothaletswa hore a khethe e itsoara joang alejiki ho lactose, tsoekere malabsorption, ka galactosemia, ka tlōlo ea ajoa bokong.

Bakeng sa ba bang ba mafu a laetsoeng lithethefatsi "Indap" e ka ba, haeba tšokelo ea kgatelelo ya madi le hore 'mele ea feta mathateng la mathata a ka' nang ba le ya kgonego itseng etsahala baeti ba fihlelang ho sona. Ho mafu a kang ascites, e leka-lekaneng renal / e amanang le sebete insufficiency, mafu a ya metsi le electrolyte ho leka-lekana, hyperuricemia, hyponatremia, hyperparathyroidism, urate nefrourolitiaz le gout. E tšoanang e sebetsa ho nako ea kanyeso.

"Indap". Litaelo ho sebelisoa. litla-morao

Tekanyo ea ho tiea tsa litla-morao itšetlehile ka lethal dose "Indap" lokisetsa. Leha ho le joalo, ka mochine oa tshitsiso ka dithulaganyo le tshilong ya dijo, bath tsa motsoako o mafolofolo moriana, o ile a etsa hore lintho tse ngata tsa litla mpe tsamaiso ea tse fapa-fapaneng tsa 'mele. Ka ho khetheha, ho na le mefuta e latelang ea litla-morao tsa lithethefatsi ena:

• tshilo ya dijo (dyspepsia, naheng ea bohloko gastrointestinal, ho nyekoa ke pelo, molomo o omileng, thothofatsang setuloana, ho hlatsa, gastralgia, ho ja) Tsamaiso;
• tsamaiso ea methapo (ho tšoha, ho tsekela, mokhathala, ho tšoaroa ke hlooho, meferefere ea sethusathuto skeletal, ho otsela, ho tepella maikutlo, lefu la ho hlobaela, teneha kapele, pherekano, matšoenyeho, ho tšoha, tsitsipano, mokhathala, asthenia, lethargy, malaise, mokhathala, spasms tsa likhoele le mesifa);
• ka le hlaphohetsoe likelellong (conjunctivitis, mafu a ea temoho bonwang);
• tsamaiso ea matšoafo (pharyngitis, rhinitis, khohlela);
• tsamaisong ea pelo le methapo (arrhythmias, palpitations, orthostatic hypotension, hypokalemia);
• ka tsamaiso ea mosese (nocturia, polyuria, khafetsa tšoaetso ea pampitšana mosese).

Ho na le boetse ho na le lehlakore le le phello "Indap" lithethefatsi kenyeletsa morao bohloko, hlōla mefuta e fapaneng ya ho tsoaetsoa mafu a, matšoao ntaramane-joaloka, bohloko sternum ea, e ile ea eketseha ho fufuleloa, meferefere ea libido le potency, shoohlo le tingling ka lipheletsong, kulisoa, ka tšohanyetso ho lahleheloa ke boima ba 'mele, hyperglycemia, hyponatremia, hyposalemia, hyperuricaemia, glycosuria, 'me palo e ba ditlolo tse ling tsa le thulaganyo tshilong ya dijo ka' mele.

Dosing

Ha ba abeloa lithethefatsi "Indap" taeo pukwanana o laola kamehla nako baeti ba fihlelang ho ka lihora tse hoseng, ke molomo, ha a lumelle litekanyetso li behoa ka kholoanyane ka lebaka la ho eketseha ka tabeng ena, kgonego ya ketsahalo ea litla-morao 'me inaccessibility tsa maemo ho tloaelehile khatello ea mali. Ha kgatelelo ya madi e nkoa e le litekanyetso li behoa ea pele ea 1.25-2.5 mg, ka letsatsi (ho liforomo neprolongirovannogo indapamide) kapa 1.5, mg (bakeng sa nako e telele liforomo indapamide) ka letsatsi. Ha ho atleha ha kalafo lithethefatsi ha hoa lekana, e lokela ho a phaella ka ho kalafo Melao ea ka mor'a libeke tse 4-8 la pheko le mekgwa e meng ea nkang khato.